Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial
Abroad (travel likely)RecruitingPHASE2
Conditions
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease · Fatty Liver Disease, Nonalcoholic · Overweight (BMI > 25)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Hospital Universitari Dr. Josep Trueta, Girona, Girona, Spain
Contact: Study coordinator (José Manuel Fernández Real Dr.) · jmfreal@idibgi.org · +34 972940200 - 2656